Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

RXL vs. IXJ: which is better?

Bottom line

RXL vs IXJ: the short answer

RXL (ProShares Ultra Health Care) and IXJ (iShares Global Healthcare ETF) share a meaningful slice of their top holdings — about 73% by weight.

IXJ is cheaper at 0.38% vs 0.95% — a difference of $57 a year per $10,000 invested.

Over five years, RXL returned +7.2% a year vs +6.4% for IXJ.

Updated Nov 19, 2026

RXL vs IXJ side by side

RXLIXJ
TypeETFETF
Fund familyProSharesiShares
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.95%0.38%
Annual cost per $10k$95$38
10-yr cost on $10k (prospectus)$1,305$480
Max front loadNoneNone
12b-1 fee—0%
1-yr return+19.7%+14.9%
5-yr return (annualized)+7.2%+6.4%
10-yr return (annualized)+12.6%+8.2%
Best quarter+29.7%+13.6%
Worst quarter−28.9%−11.8%
Net assets (fund)$72.1M$3.8B
Number of holdings70124
Portfolio turnover4%2%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearRXLIXJDifference
2025+19.7%+14.9%+4.8%
2024−2.7%+0.6%−3.3%
2023−3.2%+3.5%−6.7%
2022−15.1%−4.7%−10.4%
2021+47.8%+19.5%+28.3%
2020+19.2%+12.5%+6.8%
2019+38.9%+23.4%+15.6%
2018+5.4%+2.9%+2.5%
2017+46.0%+20.3%+25.7%
2016−8.9%−6.2%−2.7%

Source: Fund prospectus bar charts

Holdings overlap

18 of RXL's top 25 holdings also appear in IXJ's top 25.

Shared top holdings
HoldingRXLIXJ
Eli Lilly & Co.12.67%10.93%
Johnson & Johnson7.86%7.04%
AbbVie, Inc.5.57%5.12%
UnitedHealth Group, Inc.4.98%4.40%
Merck & Co., Inc.4.26%4.12%
Thermo Fisher Scientific, Inc.2.68%2.42%
Amgen, Inc.2.62%2.54%
Gilead Sciences, Inc.2.41%2.04%
Intuitive Surgical, Inc.2.18%1.83%
Pfizer, Inc.2.15%1.78%
Abbott Laboratories2.15%2.05%
Bristol-Myers Squibb Co.1.68%1.53%
CVS Health Corp.1.67%1.71%
Danaher Corp.1.66%1.56%
Vertex Pharmaceuticals, Inc.1.64%1.64%

Source: SEC Form N-PORT

RXL top 10

  1. Eli Lilly & Co. — 12.67%
  2. ProShares GENIUS Money Market ETF — 11.81%
  3. Johnson & Johnson — 7.86%
  4. AbbVie, Inc. — 5.57%
  5. UnitedHealth Group, Inc. — 4.98%
  6. Merck & Co., Inc. — 4.26%
  7. Repurchase Agreement — 2.91%
  8. Thermo Fisher Scientific, Inc. — 2.68%
  9. Amgen, Inc. — 2.62%
  10. Gilead Sciences, Inc. — 2.41%

IXJ top 10

  1. Eli Lilly And Company — 10.93%
  2. Johnson & Johnson — 7.04%
  3. Abbvie Inc. — 5.12%
  4. Unitedhealth Group Incorporated — 4.40%
  5. Merck & Co., Inc. — 4.12%
  6. Astrazeneca Plc — 3.76%
  7. Roche Holding AG — 3.75%
  8. Novartis AG — 3.71%
  9. Amgen Inc. — 2.54%
  10. Thermo Fisher Scientific Incorporated — 2.42%

FAQ

What is the difference between RXL and IXJ?
RXL (ProShares Ultra Health Care) and IXJ (iShares Global Healthcare ETF) share a meaningful slice of their top holdings — about 73% by weight. IXJ is cheaper at 0.38% vs 0.95% — a difference of $57 a year per $10,000 invested.
Which is cheaper, RXL or IXJ?
IXJ has the lower expense ratio (0.38%).
Should I own both RXL and IXJ?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.